Frontispiece: Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers (EXP2 3/2024)

The cover depicts the potential of surface‐modified nanoparticles in treating atherosclerosis by targeting over‐expressed receptors. It highlights advances in ligand‐modified nanoparticle systems for precise molecular‐level treatment and explores the challenges and future prospects, aiming to inspire novel designs of targeted nanomedicines for atherosclerosis treatment.